ResidualPlaybeta Open the radar

Fear Therapy

Black Flag Studios · 2021 · $4.99 · Indie · deal grade C

Measured on 2026-10-04 20:03 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $114 to $171 per month
  • Opportunity: $228 per month at x1.60 dormancy
  • Estimated lifetime owners: 145.0k
  • 67% positive across 4742 reviews · 4.6 reviews/month

Why it's flagged

  • Developer silent for 3.6 years
  • Studio inactive: no public activity across 1 tracked titles
  • Last discounted 3 months ago, 3 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-20; the live figures above take precedence over any numbers in it.

Fear Therapy is an indie horror game built around personalized fear-induction mechanics, designed to psychologically stress-test the player.

This title has accumulated solid lifetime reach with a meaningful positive ratio and stable residual revenue despite zero promotional activity since launch. The game's core mechanic, fear-personalization, remains technically novel and under-explored in the horror space. The dormant state and lack of developer engagement suggest the IP may be available or the studio capacity-constrained, making it a candidate for acquisition or publishing revival, though the single-title studio and gmail.com domain signal bootstrapped origins that may complicate rights clarity. Most realistic play: acquisition.

  • Risk: Single-title studio with no public posts in 43 months and no discount promotions ever run; development status and IP ownership clarity require immediate legal due diligence.
  • Risk: Currently only low single-digit concurrent players and no reviews in the last month; will require significant marketing investment to reignite visibility.
  • Risk: Early Access tag persists 7+ months with no updates; platform and feature completeness must be verified before committing resources.

This case as Markdown · Estimates carry ±30-50% error per title.